RBN-3143 is a potent, NAD+-competitive PARP14 inhibitor (IC50= 4 nM) that blocks ADP-ribosylation and stabilizes the protein in cellular models. It shows research utility for studying PARP14s role in contexts such as lung inflammation, based on findings from in vitro and in vivo investigations.